Trial Condition(s):

Erectile Dysfunction

Vardenafil Treatment Of Erectile Dysfunction In Depressive And Non-Depressive Men

Bayer Identifier:

12842

ClinicalTrials.gov Identifier:

NCT00470873

EudraCT Number:

Not Available

Study Completed

Trial Purpose

The primary aim of this open, uncontrolled, prospective, non-interventional post-marketing surveillance study is to obtain data on safety and efficacy of Levitra in routine treatment of erectile dysfunction. The secondary aim of this study is to assess the influence of the treatment with Levitra on self-esteem (depressive symptomology) in men with ED.

Inclusion Criteria
- Age over 18
 - Erectile dysfunction untreated or ineffectively treated with other than vardenafil PDE5 inhibitors
Exclusion Criteria
- Treatment with nitrates
 - Allergy to vardenafil or other tablets ingredients
 - Treatment with CYP3A4 inhibitors (e.g. indinavir, ritonavir, ketoconazole, itraconazole, erythromycin)
 - Cardiovascular status excluding any sexual activity

Trial Summary

Enrollment Goal
2471
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Levitra (Vardenafil, BAY38-9456)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many locations, Poland

Status
Completed
 

Trial Design